BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo C, Shibata K, Suzuki S, Kajiyama H, Senga T, Koya Y, Daimon M, Yamashita M, Kikkawa F. GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth. Oncol Rep 2014;32:913-21. [PMID: 24992906 DOI: 10.3892/or.2014.3300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Reference Citation Analysis]
3 Shi L, Zhang W, Zou F, Mei L, Wu G, Teng Y. KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. BMC Cancer 2016;16:815. [PMID: 27769251 DOI: 10.1186/s12885-016-2851-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
4 Cheng H, Wang Z, Fu L, Xu T. Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview. Front Oncol 2019;9:421. [PMID: 31192126 DOI: 10.3389/fonc.2019.00421] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 20.3] [Reference Citation Analysis]
5 Rai V, Abdo J, Alsuwaidan AN, Agrawal S, Sharma P, Agrawal DK. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Mol Cell Biochem 2018;437:13-36. [DOI: 10.1007/s11010-017-3092-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
6 Wu R, Guo S, Lai S, Pan G, Zhang L, Liu H. A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer. BMC Cancer 2021;21:684. [PMID: 34112138 DOI: 10.1186/s12885-021-08444-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hazekawa M, Nishinakagawa T, Kawakubo-yasukochi T, Nakashima M. Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model. Journal of Pharmacological Sciences 2019;139:231-9. [DOI: 10.1016/j.jphs.2019.01.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Martinez A, Delord JP, Ayyoub M, Devaud C. Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer. Cancers (Basel) 2020;12:E1761. [PMID: 32630708 DOI: 10.3390/cancers12071761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sun Y, Zhao J, Yin X, Yuan X, Guo J, Bi J. miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma. Cell Prolif 2016;49:636-43. [PMID: 27554041 DOI: 10.1111/cpr.12288] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
10 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]